SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
1-Year Return
0.41%
This Quarter Return
+26.4%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$539M
AUM Growth
+$122M
(+29%)
Cap. Flow
+$3.36M
Cap. Flow
% of AUM
0.62%
Top 10 Holdings %
Top 10 Hldgs %
31.99%
Holding
101
New
24
Increased
18
Reduced
29
Closed
10
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$19.5M |
| 2 |
Nova
NVMI
|
$18.1M |
| 3 |
Global E Online
GLBE
|
$10.7M |
| 4 |
Taboola.com
TBLA
|
$7.47M |
| 5 |
WIX.com
WIX
|
$7.07M |
Top Sells
| 1 |
Jasper Therapeutics
JSPR
|
$39.2M |
| 2 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
$10.3M |
| 3 |
AstraZeneca
AZN
|
$7.07M |
| 4 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
$6.35M |
| 5 |
Amazon
AMZN
|
$6.02M |
Sector Composition
| 1 | Healthcare | 72.84% |
| 2 | Technology | 18.22% |
| 3 | Communication Services | 4.34% |
| 4 | Consumer Discretionary | 3.56% |
| 5 | Utilities | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arrowhead Research
ARWR
$4.02B
| $4.43M | 0.71% |
+144,899
| New | +$4.43M |
|
52
VistaGen Therapeutics
VTGN
$109M
| $4.16M | 0.67% |
808,550
+708,550
| +709% | +$3.64M |
|
53
JFrog
FROG
$5.84B
| $3.8M | 0.61% |
+109,905
| New | +$3.8M |
|
54
PTC Therapeutics
PTCT
$4.55B
| $3.76M | 0.61% |
136,525
-81,934
| -38% | -$2.26M |
|
55
Upwork
UPWK
$2.15B
| $3.76M | 0.61% |
+252,784
| New | +$3.76M |
|
56
GSK
GSK
$81.6B
| $3.71M | 0.6% |
100,000
| – | – |
|
57
Pliant Therapeutics
PLRX
$114M
| $3.51M | 0.56% |
193,554
+37,420
| +24% | +$678K |
|
58
Enlight Renewable Energy
ENLT
$3.49B
| $3.24M | 0.52% |
+169,280
| New | +$3.24M |
|
59
Amylyx Pharmaceuticals
AMLX
$910M
| $2.7M | 0.44% |
183,650
-10,000
| -5% | -$147K |
|
60
Pfizer
PFE
$141B
| $2.59M | 0.42% |
90,000
| – | – |
|
61
Werewolf Therapeutics
HOWL
$61.7M
| $2.42M | 0.39% |
626,810
| – | – |
|
62
ProMIS Neurosciences
PMN
$22.3M
| $2.11M | 0.34% |
1,834,042
| – | – |
|
63
ICL Group
ICL
$7.85B
| $2.1M | 0.34% |
420,000
-50,000
| -11% | -$251K |
|
64
Broadcom
AVGO
$1.58T
| $2.01M | 0.32% |
+18,000
| New | +$2.01M |
|
65
Kezar Life Sciences
KZR
$29.8M
| $1.94M | 0.31% |
205,168
| – | – |
|
|
VIGL
66
DELISTED
Vigil Neuroscience
VIGL
| $1.81M | 0.29% |
+535,120
| New | +$1.81M |
|
67
Rigel Pharmaceuticals
RIGL
$742M
| $1.78M | 0.29% |
122,813
| – | – |
|
|
CRGX
68
DELISTED
CARGO Therapeutics
CRGX
| $1.74M | 0.28% |
+75,000
| New | +$1.74M |
|
69
Gilead Sciences
GILD
$143B
| $1.62M | 0.26% |
20,000
-20,000
| -50% | -$1.62M |
|
70
Cogent Biosciences
COGT
$1.82B
| $1.52M | 0.25% |
259,201
-160,799
| -38% | -$945K |
|
71
Compugen
CGEN
$134M
| $1.52M | 0.25% |
769,239
-550,000
| -42% | -$1.09M |
|
72
Gossamer Bio
GOSS
$668M
| $1.22M | 0.2% |
1,338,090
-594,478
| -31% | -$542K |
|
73
Sarepta Therapeutics
SRPT
$1.96B
| $1.21M | 0.19% |
12,500
-37,500
| -75% | -$3.62M |
|
74
FIVE9
FIVN
$2.06B
| $1.18M | 0.19% |
+15,000
| New | +$1.18M |
|
75
Oric Pharmaceuticals
ORIC
$1.06B
| $1.17M | 0.19% |
+126,800
| New | +$1.17M |
|